Connection

William Hrushesky to Time Factors

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Time Factors.
William Hrushesky
Connection Strength
0.523
Time Factors
  1. Cancer as a changed tissue's way of life (when to treat, when to watch and when to think). Future Oncol. 2016 Mar; 12(5):647-57.
    View in: PubMed
    Score: 0.071
  2. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem. 2010 Jan 29; 285(5):3030-4.
    View in: PubMed
    Score: 0.047
  3. Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007 Jul 04; 99(13):1053; author reply 1053-4.
    View in: PubMed
    Score: 0.039
  4. Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst. 2004 Jun 02; 96(11):888-9.
    View in: PubMed
    Score: 0.032
  5. Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
    View in: PubMed
    Score: 0.030
  6. Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002 Sep; 75(1):65-72.
    View in: PubMed
    Score: 0.028
  7. Circadian coordination of cancer growth and metastatic spread. Int J Cancer. 1999 Oct 29; 83(3):365-73.
    View in: PubMed
    Score: 0.023
  8. Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle. Reprod Toxicol. 1999 Sep-Oct; 13(5):413-20.
    View in: PubMed
    Score: 0.023
  9. Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar; 175(3):245-61.
    View in: PubMed
    Score: 0.021
  10. Menstrual cycle timing of breast cancer resection: prospective study is overdue. J Natl Cancer Inst. 1995 Jan 18; 87(2):143-4.
    View in: PubMed
    Score: 0.017
  11. Cancer chronotherapy: is there a right time in the day to treat? J Infus Chemother. 1995; 5(1):38-43.
    View in: PubMed
    Score: 0.017
  12. Breast cancer and the menstrual cycle. J Surg Oncol. 1993 May; 53(1):1-3.
    View in: PubMed
    Score: 0.015
  13. Optimal timing of initial breast cancer surgery. Ann Intern Med. 1992 Feb 01; 116(3):268.
    View in: PubMed
    Score: 0.014
  14. The effect of surgical timing within the fertility cycle on breast cancer outcome. Ann N Y Acad Sci. 1991; 618:277-91.
    View in: PubMed
    Score: 0.013
  15. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer. 2010 Nov 30; 10:656.
    View in: PubMed
    Score: 0.012
  16. Melatonin reprogrammes proteomic profile in light-exposed retina in vivo. Int J Biol Macromol. 2010 Aug 01; 47(2):255-60.
    View in: PubMed
    Score: 0.012
  17. Outpatient time-specified infusion of fluoropyrimidines by implanted pump is less costly than flat delivery by external pump. Prog Clin Biol Res. 1990; 341B:397-409.
    View in: PubMed
    Score: 0.012
  18. Menstrual influence on surgical cure of breast cancer. Lancet. 1989 Oct 21; 2(8669):949-52.
    View in: PubMed
    Score: 0.012
  19. Menstrual history and breast cancer surgery. Breast Cancer Res Treat. 1989 Jul; 13(3):278.
    View in: PubMed
    Score: 0.011
  20. Estrous influence on surgical cure of a mouse breast cancer. J Exp Med. 1988 Jul 01; 168(1):73-83.
    View in: PubMed
    Score: 0.011
  21. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS. 2008 Jul-Aug; 116(7-8):730-41.
    View in: PubMed
    Score: 0.011
  22. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression. Pharmacotherapy. 1988; 8(1):47-51.
    View in: PubMed
    Score: 0.010
  23. Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006; 6(1):73-84.
    View in: PubMed
    Score: 0.009
  24. Circadian toxicology of cyclosporin. Toxicol Appl Pharmacol. 1985 Jan; 77(1):181-5.
    View in: PubMed
    Score: 0.008
  25. The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
    View in: PubMed
    Score: 0.008
  26. Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 1982 Mar; 42(3):945-9.
    View in: PubMed
    Score: 0.007
  27. Irreversible inactivation of interleukin 2 in a pump-based delivery environment. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5460-5.
    View in: PubMed
    Score: 0.005
  28. Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst. 1972 Oct; 49(4):1077-83.
    View in: PubMed
    Score: 0.004
  29. A pharmacist's primer on chronotherapeutics. Am Pharm. 1992 Mar; NS32(3):77-83.
    View in: PubMed
    Score: 0.003
  30. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 1982 Mar; 42(3):950-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.